Shopping Cart 0
Cart Subtotal
USD 0

Oncgnostics GmbH - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that offers development of in-vitro diagnostic tests for the therapeutics area of cancer. The company offers pipeline products such as GynTect technology a system based on the detection of epigenetic biomarkers mainly in the methylation of specific DNA regions. Its GynTect also allows a fast and reliable detection of cervical precancerous lesions and cancer. Oncgnostics' pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors, among others. The company also provides IVD test development field after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Oncgnostics GmbH

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Oncgnostics GmbH Company Overview

Oncgnostics GmbH Company Snapshot

Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview

Oncgnostics GmbH-Pipeline Analysis Overview

Oncgnostics GmbH-Key Facts

Oncgnostics GmbH-Major Products and Services

Oncgnostics GmbH Pipeline Products by Development Stage

Oncgnostics GmbH Pipeline Products Overview

GynTect

GynTect Product Overview

Oncgnostics Diagnostic Test-Head & Neck Cancer

Oncgnostics Diagnostic Test-Head & Neck Cancer Product Overview

Oncgnostics Diagnostic Test-Ovarian Cancer

Oncgnostics Diagnostic Test-Ovarian Cancer Product Overview

Oncgnostics GmbH-Key Competitors

Oncgnostics GmbH-Key Employees

Oncgnostics GmbH-Locations And Subsidiaries

Head Office

Recent Developments

Oncgnostics GmbH, Recent Developments

Feb 20, 2019: Early detection test GynTect now available on Roche Diagnostics' QPCR system

May 18, 2018: Oncgnostics and Blink presented BMBF research project "ASSURER"

Sep 27, 2017: Better diagnosis of cervix cancer: New InfectoGnostics project "ASSURER" funded by the BMBF

Sep 20, 2016: Early Detection of Ervical cancer: GynTect 2.0- Wider Range of Application by Using a Greater Variety of Patient Samples

Apr 28, 2016: Oncgnostics cooperates with SAYRE Therapeutics in India

Jan 20, 2016: Safe Diagnostics for Women Tested HPV-Positive

Sep 18, 2015: Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test "GynTect"

Nov 25, 2014: Oncgnostics Received Award At The Thuringian Innovation Prize 2014

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Oncgnostics GmbH Pipeline Products by Equipment Type

Oncgnostics GmbH Pipeline Products by Development Stage


List Of Table

List of Tables

Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview

Oncgnostics GmbH Pipeline Products by Equipment Type

Oncgnostics GmbH Pipeline Products by Indication

Oncgnostics GmbH, Key Facts

Oncgnostics GmbH, Major Products and Services

Oncgnostics GmbH Number of Pipeline Products by Development Stage

Oncgnostics GmbH Pipeline Products Summary by Development Stage

GynTect-Product Status

GynTect-Product Description

Oncgnostics Diagnostic Test-Head & Neck Cancer-Product Status

Oncgnostics Diagnostic Test-Head & Neck Cancer-Product Description

Oncgnostics Diagnostic Test-Ovarian Cancer-Product Status

Oncgnostics Diagnostic Test-Ovarian Cancer-Product Description

Oncgnostics GmbH, Key Employees

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Oncgnostics GmbH, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

biosyn Arzneimittel GmbH

BIOTECON Diagnostics GmbH

BioNTech SE

Company Profile

Company Profile Title

Summary

Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that offers development of in-vitro diagnostic tests for the therapeutics area of cancer. The company offers pipeline products such as GynTect technology a system based on the detection of epigenetic biomarkers mainly in the methylation of specific DNA regions. Its GynTect also allows a fast and reliable detection of cervical precancerous lesions and cancer. Oncgnostics' pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors, among others. The company also provides IVD test development field after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Oncgnostics GmbH

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Oncgnostics GmbH Company Overview

Oncgnostics GmbH Company Snapshot

Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview

Oncgnostics GmbH-Pipeline Analysis Overview

Oncgnostics GmbH-Key Facts

Oncgnostics GmbH-Major Products and Services

Oncgnostics GmbH Pipeline Products by Development Stage

Oncgnostics GmbH Pipeline Products Overview

GynTect

GynTect Product Overview

Oncgnostics Diagnostic Test-Head & Neck Cancer

Oncgnostics Diagnostic Test-Head & Neck Cancer Product Overview

Oncgnostics Diagnostic Test-Ovarian Cancer

Oncgnostics Diagnostic Test-Ovarian Cancer Product Overview

Oncgnostics GmbH-Key Competitors

Oncgnostics GmbH-Key Employees

Oncgnostics GmbH-Locations And Subsidiaries

Head Office

Recent Developments

Oncgnostics GmbH, Recent Developments

Feb 20, 2019: Early detection test GynTect now available on Roche Diagnostics' QPCR system

May 18, 2018: Oncgnostics and Blink presented BMBF research project "ASSURER"

Sep 27, 2017: Better diagnosis of cervix cancer: New InfectoGnostics project "ASSURER" funded by the BMBF

Sep 20, 2016: Early Detection of Ervical cancer: GynTect 2.0- Wider Range of Application by Using a Greater Variety of Patient Samples

Apr 28, 2016: Oncgnostics cooperates with SAYRE Therapeutics in India

Jan 20, 2016: Safe Diagnostics for Women Tested HPV-Positive

Sep 18, 2015: Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test "GynTect"

Nov 25, 2014: Oncgnostics Received Award At The Thuringian Innovation Prize 2014

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Oncgnostics GmbH Pipeline Products by Equipment Type

Oncgnostics GmbH Pipeline Products by Development Stage


List Of Table

List of Tables

Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview

Oncgnostics GmbH Pipeline Products by Equipment Type

Oncgnostics GmbH Pipeline Products by Indication

Oncgnostics GmbH, Key Facts

Oncgnostics GmbH, Major Products and Services

Oncgnostics GmbH Number of Pipeline Products by Development Stage

Oncgnostics GmbH Pipeline Products Summary by Development Stage

GynTect-Product Status

GynTect-Product Description

Oncgnostics Diagnostic Test-Head & Neck Cancer-Product Status

Oncgnostics Diagnostic Test-Head & Neck Cancer-Product Description

Oncgnostics Diagnostic Test-Ovarian Cancer-Product Status

Oncgnostics Diagnostic Test-Ovarian Cancer-Product Description

Oncgnostics GmbH, Key Employees

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Oncgnostics GmbH, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

biosyn Arzneimittel GmbH

BIOTECON Diagnostics GmbH

BioNTech SE